Imugene key HER-Vaxx patent granted in Europe
Filed with ASX · · 2 pages · English
Later from Imugene
- Partnership to Develop Mimotope Immuno-Oncology Platform
- Manufacturing Update
- Imugene Announces Successful Capital Raising
- Regulatory package submission for Her-Vaxx in Hong Kong
- Imugene Receives Institutional Review Board Approval
Follow Imugene into a list and get an email when it puts out news.
Follow Imugene